Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
161.41M | 83.37M | 57.57M | -122.65M | -5.36M | 4.75M | Gross Profit |
161.41M | 84.39M | 57.57M | -122.71M | -5.37M | 4.75M | EBIT |
159.29M | 83.44M | 45.66M | -136.31M | -19.09M | -5.18M | EBITDA |
15.02M | 71.68M | 0.00 | 0.00 | -19.10M | -5.18M | Net Income Common Stockholders |
106.49M | 50.93M | 32.73M | -94.84M | -12.46M | -2.68M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
253.53M | 619.48M | 539.20M | 309.58M | 123.59M | 52.26M | Total Assets |
550.74M | 730.51M | 681.35M | 647.09M | 987.05M | 834.68M | Total Debt |
0.00 | 6.99M | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-253.53M | -58.93M | -59.25M | -122.03M | -123.59M | -52.26M | Total Liabilities |
― | 33.10M | 5.83M | 5.96M | 65.34M | 50.67M | Stockholders Equity |
535.23M | 697.41M | 675.52M | 641.13M | 886.00M | 750.51M |
Cash Flow | Free Cash Flow | ||||
-947.85K | -3.30M | 7.60M | -94.84M | -56.91M | -1.20M | Operating Cash Flow |
-947.85K | -3.30M | 7.60M | -94.84M | -56.91M | -1.20M | Investing Cash Flow |
56.98M | 42.57M | -43.86M | 73.57M | 161.32M | -14.45M | Financing Cash Flow |
-32.73M | -31.57M | -28.56M | -25.28M | -22.46M | 62.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | 5.42 | 17.47% | 5.10% | 13884.14% | 466.16% | ||
64 Neutral | $12.64B | 9.78 | 7.67% | 17015.08% | 12.26% | -6.03% | |
$3.37B | 32.26 | 3.85% | 4.08% | ― | ― | ||
€824.80M | 5.98 | 23.27% | 8.19% | ― | ― | ||
€183.98M | 11.13 | 9.63% | 10.95% | ― | ― | ||
81 Outperform | AU$6.44B | 9.75 | 110.61% | 9.62% | 47.63% | 53.44% | |
72 Outperform | 22.36 | 4.44% | 4.66% | -4.33% | -13.07% |
Hearts and Minds Investments Ltd announced its Net Tangible Asset (NTA) backing per share as of May 2, 2025. The pre-tax NTA was reported at $3.34, post-current tax NTA at $3.26, and post-tax NTA at $3.17, reflecting slight increases from the previous week. This update indicates a stable financial position, potentially reassuring stakeholders about the company’s asset management effectiveness.
Hearts and Minds Investments Limited announced a change in the director’s interest, with Guy Fowler acquiring an additional 36,352 fully paid ordinary shares through the company’s Dividend Reinvestment Plan. This change increases his total holding to 1,426,211 shares, reflecting a strategic move to enhance his stake in the company, potentially signaling confidence in the company’s future performance.
Hearts and Minds Investments Limited announced its Net Tangible Asset (NTA) backing per share as of April 17, 2025, with a slight decrease compared to the previous week. The pre-tax NTA was reported at $3.16, post-current tax NTA at $3.08, and post-tax NTA at $3.04. This update reflects minor fluctuations in the company’s asset valuation, which may influence investor perceptions and market positioning.
In March 2025, Hearts and Minds Investments Ltd reported a challenging month with its portfolio down 8.85%, underperforming the MSCI World Index (AUD) which fell by 5.19%. The company has delivered an annualized pre-tax investment return of 10.39% since inception. Market volatility was driven by U.S. trade policy uncertainties and recession fears, with no immediate response from the government or the Federal Reserve. The company’s investment in Opthea was written down to zero following disappointing Phase 3 trial results. Despite these challenges, the company maintains a fully franked annualized dividend yield of 5.5% and continues to support medical research funding.
Hearts and Minds Investments Ltd announced its Net Tangible Asset (NTA) backing per share as of April 4, 2025, with a pre-tax NTA of $3.13, a post-current tax NTA of $3.05, and a post-tax NTA of $3.03. These figures reflect the company’s financial position after accounting for a recently announced dividend, indicating a slight decrease from the previous week, which could impact investor perceptions and market positioning.
Hearts and Minds Investments Limited announced a significant write-down of its holding in Opthea Limited, a biopharmaceutical company specializing in eye disease treatments. The decision to reduce the value of Opthea shares to zero follows the failure of a second phase three trial for a treatment, impacting HM1’s net asset value by approximately 0.8%.
Hearts and Minds Investments Ltd has updated its previous announcement regarding the dividend distribution for its ordinary fully paid securities. The update provides details on the Dividend Reinvestment Plan (DRP) price, which relates to the financial period ending December 31, 2024. This announcement is significant for stakeholders as it clarifies the dividend distribution details, impacting investor decisions and shareholder returns.
Hearts and Minds Investments Ltd announced its Net Tangible Asset (NTA) backing per share as of March 28, 2025. The figures show a decrease in NTA values compared to the previous week, reflecting the impact of the recently announced dividend. This announcement indicates a slight decline in the company’s asset value, which may influence investor sentiment and market positioning.
Hearts and Minds Investments Limited (HM1) has announced an update regarding its investment in Opthea Limited (OPT), a biopharmaceutical company focused on developing therapies for eye diseases. OPT reported negative results from a Phase 3 clinical trial of its lead drug candidate, leading to a suspension of its securities on the ASX and Nasdaq. Consequently, HM1 has revalued its holding in OPT, impacting its net asset value by approximately 1.6%. This adjustment reflects the potential for future positive outcomes from upcoming trials.
Hearts and Minds Investments Limited announced its Net Tangible Asset (NTA) backing per share as of March 21, 2025. The NTA figures, which are adjusted for a recently announced dividend, show a slight increase compared to the previous week, indicating stable financial performance and potential positive implications for shareholders.
Hearts and Minds Investments Ltd announced its estimated Net Tangible Asset (NTA) backing per share as of March 14, 2025, with pre-tax, post-current tax, and post-tax NTAs showing slight decreases compared to February 7, 2025. The announcement also highlighted the company’s recently declared fully franked half-yearly dividend and the availability of a Dividend Reinvestment Plan, which may impact shareholder decisions and company liquidity.
Hearts and Minds Investments Limited reported a 3.75% decline in its portfolio for February, underperforming the MSCI World Index. Despite this, the company has achieved an annualized pre-tax investment return of 12.16% since its inception. The company announced an increased half-year fully franked dividend of 8.0 cents per share, reflecting significant profit growth for the half-year ending December 2024. Additionally, Brett Jollie was appointed as the new CEO, bringing extensive experience in funds management and a commitment to the company’s mission of supporting medical research.
Hearts and Minds Investments Limited announced its Net Tangible Asset (NTA) backing per share as of February 28, 2025, reflecting a slight decrease from the previous week. The company also highlighted the availability of its Dividend Reinvestment Plan for shareholders, with elections due by March 12, 2025, allowing them to reinvest dividends into additional shares, potentially impacting shareholder value and investment strategies.
Hearts and Minds Investments Limited announced its Net Tangible Asset (NTA) backing per share as of February 21, 2025, demonstrating a decrease compared to the prior week, with pre-tax NTA at $3.76, post-current tax NTA at $3.68, and post-tax NTA at $3.49. The announcement includes the provision for a fully franked half-yearly dividend of 8.0 cents per share, emphasizing the company’s commitment to delivering shareholder value while offering the Dividend Reinvestment Plan for increased investment flexibility.
Hearts and Minds Investments Ltd announced an increased half-year fully franked dividend of 8.0 cents per share, driven by strong investment performance and a significant rise in profits for the half year ending December 31, 2024. The company reported a total comprehensive income after tax of $115.3 million, a substantial increase from the previous year, with investment returns bolstered by a weaker Australian dollar. Key performers in their portfolio included Zillow, Guzman y Gomez, and Brookfield Corp. Additionally, HM1’s commitment to philanthropy is demonstrated through its $4.5 million funding to medical research in the same period. The announcement also marks a leadership transition with Brett Jollie taking over as CEO.
Hearts and Minds Investments Limited reported a significant increase in its financial performance for the half year ended 31 December 2024, with a total comprehensive income after tax of $115.3 million, driven by strong returns from its investment portfolio and favorable market conditions. The company declared a fully franked dividend of 8.0 cents per share and continued its philanthropic support for medical research, donating $4.5 million and accruing an additional $5.6 million for future contributions.
Hearts and Minds Investments Limited, an investment company, announced its Net Tangible Asset (NTA) backing per share as of February 14, 2025. The figures reported include Pre Tax NTA at $3.85, Post Current Tax NTA at $3.77, and Post Tax NTA at $3.56. The announcement comes ahead of a recently declared fully franked half-yearly dividend of 8.0 cents per share, with an ex-dividend date of February 26, 2025, and payment scheduled for April 17, 2025. Shareholders are given the option to participate in the Dividend Reinvestment Plan, with election changes due by March 12, 2025.
Hearts and Minds Investments Ltd announced its Net Tangible Asset (NTA) backing per share as of February 7, 2025, with a pre-tax NTA of $3.91, post-current tax NTA of $3.87, and post-tax NTA of $3.60. The announcement also highlighted the upcoming fully franked half-yearly dividend of 8.0 cents per share, payable on April 17, 2025, with a Dividend Reinvestment Plan available for shareholders.
Hearts and Minds Investments Limited announced a positive start to 2025, with a portfolio increase of 5.2% in January compared to the MSCI World Index’s 2.3% rise. A significant revaluation of its investment in Rokt Inc. from US$25 to US$35 per share marked a 61% unrealized gain. This robust performance led to an early announcement of an increased fully franked half-yearly dividend of 8.0 cents per share, expected to narrow the share price discount to its pre-tax net tangible assets.